Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Bucky86on Apr 08, 2021 1:09pm
148 Views
Post# 32957476

couple things

couple things1. Great to see 80%+ of people have changed their names/new accounts - thats always a promising sign of a good stock. (not) - (bashers and pumpers)

2. Claurus lowering their target price is a huge red flag for me.... it went nowhere close to their previous $4 mark and I doubt it will go to the $1.25 anytime soon.

3. If people on this board are still unappologetically optimistic i feel sorry for you. Yes you could argue it might be a time to "load up" but good lord its GROUND HOG day with this stock quarter after quarter.

I'm on the sidelines waiting with this one.... will take a lot to get me back in. More then people trying to find broken links in the dark alleys of a website. (you think thats the sign of a good company) haha

Bucky 
<< Previous
Bullboard Posts
Next >>